Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) with central nervous system activity. It is commonly employed in the production of antidepressants, antipsychotics, and other neurologically targeted drugs due to its ability to enhance metabolic stability and bioavailability. The trifluoromethyl group contributes to increased lipophilicity and resistance to oxidative degradation, making it valuable in medicinal chemistry for improving drug potency and half-life. Also utilized in agrochemicals for the design of novel pesticides and herbicides where enhanced environmental stability is required.